UK markets closed

Israel Chemicals Ltd. (ICL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
4.6850-0.0650 (-1.37%)
As of 03:30PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 5.76B
Enterprise value 7.78B
Trailing P/E 13.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.86
Price/book (mrq)1.06
Enterprise value/revenue 1.09
Enterprise value/EBITDA 5.53

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-24.84%
S&P500 52-week change 328.04%
52-week high 36.7300
52-week low 34.3000
50-day moving average 34.9088
200-day moving average 35.1588

Share statistics

Avg vol (3-month) 3685.02k
Avg vol (10-day) 3452.98k
Shares outstanding 51.29B
Implied shares outstanding 61.31B
Float 8721.12M
% held by insiders 144.06%
% held by institutions 122.98%
Shares short (30 Apr 2024) 41.19M
Short ratio (30 Apr 2024) 41.85
Short % of float (30 Apr 2024) 40.16%
Short % of shares outstanding (30 Apr 2024) 40.09%
Shares short (prior month 28 Mar 2024) 41.66M

Dividends & splits

Forward annual dividend rate 40.18
Forward annual dividend yield 43.85%
Trailing annual dividend rate 30.21
Trailing annual dividend yield 34.51%
5-year average dividend yield 45.84
Payout ratio 476.40%
Dividend date 320 Jun 2024
Ex-dividend date 406 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 6.65%
Operating margin (ttm)11.70%

Management effectiveness

Return on assets (ttm)4.59%
Return on equity (ttm)8.69%

Income statement

Revenue (ttm)7.15B
Revenue per share (ttm)5.55
Quarterly revenue growth (yoy)-18.00%
Gross profit (ttm)N/A
EBITDA 1.32B
Net income avi to common (ttm)476M
Diluted EPS (ttm)0.3600
Quarterly earnings growth (yoy)-61.10%

Balance sheet

Total cash (mrq)484M
Total cash per share (mrq)0.38
Total debt (mrq)2.51B
Total debt/equity (mrq)41.46%
Current ratio (mrq)1.60
Book value per share (mrq)4.47

Cash flow statement

Operating cash flow (ttm)1.49B
Levered free cash flow (ttm)682.5M